InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,611.69
(
-0.39%
)
US TECH 100
19,930.75
(
-0.93%
)
Dow Jones
39,773.17
(
0.13%
)
Brent Oil
85.12
(
0.08%
)
Bitcoin
57,817.50
(
0.11%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12477
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Wednesday, 08/04/2010 2:18:56 PM

Wednesday, August 04, 2010 2:18:56 PM

Post# of 80490
I guess what worries me the most is Harvey's choice of words when he talks about Ridaforolimus recently. One year ago, he was all full of vigor and energy for Rida, and this energy has slowly progressed lower, to where, for the first time today, he actually used twice the words, "if it passes or fails". He has never expressed himself like that before.. I hold out much hope, in that Merck just ponied up $70 million for the rights..
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up